Royalty Pharma’s $1.3 Billion Senior Notes Offering

Davis Polk advised Royalty Pharma plc on the transaction.Royalty Pharma executed its offering of $1.3 billion aggregate principal amount of senior notes. The offering consisted of $600…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now